Waters Corporation Opens State-of-the-Art Precision Manufacturing Facility in Longbridge, UK
Newly built 45,000 sq ft facility houses engineering and skilled manufacturing employees at Longbridge Business Park, a ...
Gyre Therapeutics, Inc.: Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update
Last patient completed pivotal Phase 3 trial in CHB-associated liver fibrosis in the PRC with data expected in Q1 2025 On track to initiate U.S. Phase 2 trial of F351 in MASH-associated liver fibrosis ...